How Effective are Retail Brand Skin Care?
Independent laboratory testing has revealed that the large majority of face creams including some big named brands fail to deliver meaningful, measurable anti-ageing effects below the skin’s surface, primarily because active ingredients are present at concentrations too low to produce biological change.
Two related investigations reported by Australian Beauty Digest examined this issue. One evaluated 127 internationally available face creams for functional performance at deeper skin layers. The other focused on 62 creams marketed for wrinkles or firmness, prioritising quantitative measurement of active-ingredient concentrations. Both were conducted independently of manufacturers, with products purchased anonymously from retail sources (pharmacies, department stores and online) across a wide price range.
Researchers and Oversight
The work was led by an independent team of dermatologists and cosmetic chemists. Professor Charlotte Weber, MD, a board-certified dermatologist with 25 years specialising in ageing skin, served as principal investigator and chair of the review board. Marcus Bauer, PhD, a dermatological research scientist with 26 years of experience (including development of laboratory methods for measuring collagen production), conducted key analytical work, particularly the concentration measurements. Dr Laura Schmidt, MD, FRCP, a consultant dermatologist specialising in non-invasive skin rejuvenation who has performed over 15,000 anti-ageing treatments, supervised the clinical trials across multiple testing sites. An expert panel with no financial ties to any manufacturer reviewed the protocols and findings to confirm they met academic standards. Supporting context included analysis of hundreds of prior clinical studies and a survey of European dermatologists about their own product criteria.
Methods
Both studies emphasised objective, instrument-based measurement rather than subjective consumer perception alone.
In the concentration-focused study of 62 creams, Phase 1 used high-performance liquid chromatography with ultraviolet detection (HPLC-UV) to quantify declared active ingredients. Samples were decanted, coded and stripped of packaging; each product underwent two independent runs. This established whether actives reached levels capable of biological activity. Phase 2 involved a 12-week clinical trial with 412 women aged 42–68. Participants applied one assigned cream twice daily. Measurements included cutometry for elasticity and firmness, DermaScan 3D surface imaging for wrinkle depth (at baseline and weeks 4, 8 and 12), and assessment of barrier function and other parameters. A panel of 200 members of the public estimated perceived age from randomised before-and-after photographs.

The broader evaluation of 127 creams employed a 12-point protocol assessing both appearance and function: laboratory verification of active-ingredient concentration; direct testing of collagen production in skin samples; profilometry and 3D skin scanning for wrinkle depth under standardised lighting; Cutometer R2 readings for elasticity and firmness; Corneometer hydration measurements over 24 hours and 12 weeks; TEWL (trans-epidermal water loss) for barrier function; Mexameter readings for pigmentation; cellular renewal markers; clinical photography; dermatological compatibility testing; application properties; and long-term observation over six months. Testing followed standardised protocols under DIN EN ISO 22716 for reproducibility, with all products acquired anonymously and evaluated without manufacturer input.
Researchers framed skin ageing as occurring at three distinct levels requiring different interventions. The surface level involves visible dryness, fine lines and temporary plumpness addressed by conventional moisturisers. The structural level concerns progressive breakdown of collagen (approximately 1 % per year after age 20) and elastin, targeted by peptides and retinoids. The cellular level involves slowed cell division (renewal cycles lengthening from roughly 28 to 40 days), accumulation of senescent “zombie” cells that release degrading signals, and declining fibroblast activity—the root drivers that limit the effectiveness of surface or structural treatments alone.
Key Findings
(1) In the 62-cream analysis, half the products contained less than 0.5 % of the advertised active; a further substantial portion fell between 0.5 % and 2 %. Only a small minority exceeded the approximate 2 % threshold needed for measurable activity. Price showed virtually no correlation with concentration (statistically indistinguishable from zero). An expensive luxury product could measure well below threshold, while some lower-priced options cleared it. Ingredient lists, required to appear in descending order of concentration only down to 1 %, provided no reliable guide to actual potency below that level.
Below roughly 2 %, instruments recorded essentially no measurable change in skin parameters over 12 weeks. Above that threshold, the same molecules produced detectable effects from week 4 onward. The chemistry is straightforward: an active must generate a sufficient concentration gradient to cross the stratum corneum (the outer barrier of dead cells designed to keep foreign molecules out). Sub-threshold amounts remain on the surface, producing temporary hydration and cosmetic smoothing that fades, while adequate amounts reach deeper layers where structural and cellular processes occur.
Most creams therefore function primarily as surface treatments. They improve hydration and temporary appearance but leave structural collagen loss and cellular slowdown unaddressed. Clinical timelines consistently showed early hydration gains (weeks 1–2), modest texture changes (weeks 3–4), and some firmness improvements by weeks 6–8 for products with adequate actives. Surface-only formulas plateaued thereafter, while those capable of deeper action continued to show progressive change through week 12 and beyond.
(2) Complementary combinations of actives outperformed single “hero” ingredients; ageing involves multiple concurrent problems, so multi-mechanism formulas with synergistic modes of action that address moisture, structure and cellular behaviour simultaneously produce more sustained results compared to products that do not address multiple issues.
Dermatologist criteria aligned with these measurements: preference for multi-level action rather than surface-only effects; prioritisation of cellular change over rapid cosmetic improvement; verifiable doses of a limited number of actives rather than long, diluted lists; testing on age-appropriate participants; and progressive rather than plateauing results.
Conclusion
The studies concluded that the majority of retail face creams are formulated with subclinical concentrations of actives—present on the label for marketing but insufficient to alter the biological processes driving visible ageing. This explains why many users experience short-term sensory benefits followed by frustration and product switching: the formulas were never designed to reach or meaningfully influence the deeper layers where lasting change occurs.
Taken together, the investigations demonstrate that independent laboratory quantification of concentration, combined with instrumented clinical measurement of function over time, reveals a widespread gap between marketing claims and measurable biological performance in the face-cream category.
Here at PLC we have been stating these finding to be the case for many years and now the tests have been performed to prove it. Unlike many retail brands we ensure our formulations contain hero ingredients with synergistic modes of action to address multiple aspects of aging skin. We also ensure that the hero ingredients are used at effective levels and not just listed for marketing purposes. By adhering to these principles we ensure the cosmeceticals produced by PLC are effective.
Reference:
(1) Only 5 of 127 Face Creams Measurably Worked Below the Surface in Lab Testing. The Top-Ranked Cream Reduced Wrinkle Depth by 31% (127 Products Tested)
(2) Lab Test: Only 4 Of 62 Face Creams Contained Enough Active Ingredient To Do Anything





Comments